Skip to main content
logo
Korsana Biosciences, Inc. (KRSA)
NASDAQ: KRSA · Real-Time Price · USD
31.42
-0.58 (-1.81%)
Oct 1, 2026, 3:42 PM EDT - Market open

Korsana Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Cash & Equivalents
134.16154.1410.11
Cash & Short-Term Investments
134.16154.1410.11
Cash Growth
-1424.88%-
Prepaid Expenses
0.950.46-
Total Current Assets
135.11154.610.11
Total Assets
137.7154.610.11

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Accounts Payable
-0.180.07
Accrued Expenses
7.412.310.01
Total Current Liabilities
7.7712.490.08
Other Long-Term Liabilities
0.480.54-
Total Liabilities
9.1913.030.08

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Common Stock
000
Additional Paid-In Capital
2.211.760.15
Retained Earnings
-49.24-35.73-0.09
Total Common Equity
-47.03-33.970.07
Shareholders' Equity
128.51141.5710.03
Total Liabilities & Equity
137.7154.610.11

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Net Cash (Debt)
133.07154.1410.11
Net Cash Growth
-1424.88%-
Net Cash Per Share
36.2552.786.70
Filing Date Shares Outstanding
661.51
Total Common Shares Outstanding
661.51
Working Capital
127.34142.1110.03
Book Value Per Share
-7.84-5.660.04
Tangible Book Value
-47.03-33.970.07
Tangible Book Value Per Share
-7.84-5.660.04